4.01
0.75%
0.03
Larimar Therapeutics Inc (LRMR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.16%
16.73
|
14.16 | 10.34 | 9.62 | 7.637 |
Operating Income/Loss |
18.16%
-16.73
|
-14.16 | -10.34 | -9.62 | -7.637 |
Nonoperating Income/Loss |
77.93%
2.08
|
1.169 | 1.275 | 1.254 | 1.111 |
Income/Loss From Continuing Operations Before Tax |
12.78%
-14.65
|
-12.99 | -9.064 | -8.366 | -6.526 |
Income/Loss From Continuing Operations After Tax |
12.78%
-14.65
|
-12.99 | -9.064 | -8.366 | -6.526 |
Net Income/Loss
|
12.78%
-14.65
|
-12.99 | -9.064 | -8.366 | -6.526 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3.41M%
53.55
|
0.00157 | 43.90 | 43.90 | 43.90 |
Diluted Average Shares |
3.41M%
53.55
|
0.00157 | 43.90 | 43.90 | 43.90 |
Basic Earnings Per Share |
6.90%
-0.27
|
-0.29 | -0.21 | -0.19 | -0.15 |
Diluted Earnings Per Share |
6.90%
-0.27
|
-0.29 | -0.21 | -0.19 | -0.15 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):